Ubs Group Ag Alx Oncology Holdings Inc Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Ubs Group Ag holds 256,493 shares of ALXO stock, worth $159,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

256,493

Previous 408,056 37.14%

Holding current value

$159,025

Previous $681,000 76.65%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.62 - $1.86 $93,969 - $281,907	-151,563 Reduced 37.14%	256,493 $159,000
Q4 2024 Feb 14, 2025	BUY	$1.21 - $1.87 $458,367 - $708,385	378,816 Added 1295.54%	408,056 $681,000
Q3 2024 Nov 14, 2024	BUY	$1.81 - $8.13 $24,954 - $112,088	13,787 Added 89.22%	29,240 $53,000
Q2 2024 Aug 13, 2024	SELL	$5.84 - $17.56 $79,546 - $239,184	-13,621 Reduced 46.85%	15,453 $93,000
Q1 2024 May 13, 2024	SELL	$10.95 - $16.79 $20,958 - $32,136	-1,914 Reduced 6.18%	29,074 $324,000
Q4 2023 Feb 09, 2024	BUY	$4.81 - $15.38 $95,209 - $304,431	19,794 Added 176.83%	30,988 $461,000
Q3 2023 Nov 09, 2023	SELL	$4.19 - $7.35 $4,893 - $8,584	-1,168 Reduced 9.45%	11,194 $53,000
Q2 2023 Aug 11, 2023	BUY	$4.37 - $9.56 $10,134 - $22,169	2,319 Added 23.09%	12,362 $92,000
Q1 2023 May 12, 2023	BUY	$4.52 - $11.71 $12,660 - $32,799	2,801 Added 38.68%	10,043 $45,000
Q4 2022 Feb 08, 2023	BUY	$9.51 - $12.95 $68,871 - $93,783	7,242 New	7,242 $81,000
Q2 2022 Aug 10, 2022	SELL	$5.89 - $19.46 $506,964 - $1.67 Million	-86,072 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.65 - $22.06 $105,459 - $170,435	-7,726 Reduced 8.24%	86,072 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $1.86 Million - $6.44 Million	86,532 Added 1190.92%	93,798 $2.02 Million
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $132,745 - $204,540	2,528 Added 53.36%	7,266 $537,000
Q2 2021 Aug 13, 2021	SELL	$52.2 - $75.23 $741,762 - $1.07 Million	-14,210 Reduced 74.99%	4,738 $259,000
Q1 2021 May 12, 2021	BUY	$62.84 - $87.68 $1.19 Million - $1.66 Million	18,898 Added 37796.0%	18,948 $1.4 Million
Q4 2020 Feb 11, 2021	BUY	$34.11 - $112.26 $1,705 - $5,613	50 New	50 $4,000

Others Institutions Holding ALXO

# of Institutions

Shares Held

33.6M

Call Options Held

34K

Put Options Held

36.9K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $25.3M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account